iBio, Inc. (IBIO) Free cash flow 2016–2025
iBio, Inc. (IBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.3MFY2025 · since FY2016: -$8.1M → -$15.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.3M | +18.4% |
| FY2024 | -$18.8M | +48.1% |
| FY2023 | -$36.2M | +19.3% |
| FY2022 | -$44.8M | -28.1% |
| FY2021 | -$35.0M | -142.6% |
| FY2020 | -$14.4M | +3.2% |
| FY2019 | -$14.9M | -3.3% |
| FY2018 | -$14.4M | +0.5% |
| FY2017 | -$14.5M | -78.0% |
| FY2016 | -$8.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice